Overview
Jose Tarriba-Telich practices in Mexico City, Mexico. Mr. Tarriba-Telich is rated as an Experienced expert by MediFind in the treatment of Micrognathia. His top areas of expertise are Moebius Syndrome, Charlie M Syndrome, Facial Paralysis, and Poland Syndrome.
His clinical research consists of co-authoring 32 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Micrognathia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Charlie M SyndromeMr. Tarriba-Telich isElite. Learn about Charlie M Syndrome.
- Moebius SyndromeMr. Tarriba-Telich isElite. Learn about Moebius Syndrome.
- Distinguished
- Facial ParalysisMr. Tarriba-Telich isDistinguished. Learn about Facial Paralysis.
- Experienced
- Acrofacial Dysostosis Rodriguez TypeMr. Tarriba-Telich isExperienced. Learn about Acrofacial Dysostosis Rodriguez Type.
- Acrofrontofacionasal Dysostosis SyndromeMr. Tarriba-Telich isExperienced. Learn about Acrofrontofacionasal Dysostosis Syndrome.
- Acromicric DysplasiaMr. Tarriba-Telich isExperienced. Learn about Acromicric Dysplasia.
- Bell's PalsyMr. Tarriba-Telich isExperienced. Learn about Bell's Palsy.
- Breast CancerMr. Tarriba-Telich isExperienced. Learn about Breast Cancer.
- Crouzon SyndromeMr. Tarriba-Telich isExperienced. Learn about Crouzon Syndrome.